Virios Therapeutics (VIRI) Tops Q2 EPS by 7c

Virios Therapeutics (NASDAQ: VIRI) reported Q2 EPS of ($0.44), $0.07 better than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• BofA lists top 5 themes driving next $1tn in incremental semi sales
• Winnebago Industries (WGO) PT Lowered to $40 at Benchmark on Pressured NT Demand
• Sunstone Hotel Investors to sell Hyatt Regency San Francisco for $279M